Attachment 12.3 References

Show / hide chapter menu

12.0 Introduction

12.1 Tobacco in Australian cigarettes

12.2 Measuring cigarette smoke constituents

12.3 Labelling of 'tar', nicotine and carbon monoxide yields of Australian cigarettes

12.4 General engineering features of Australian cigarettes and their relation to compensatory smoking

12.5 Comparison of Australian and United States cigarettes

12.6 Comparison of Australian cigarettes in different yield categories

12.7 Additives in Australian cigarettes

12.8 Flavoured cigarettes

12.9 Specific carcinogens and cardiovascular toxicants in Australian cigarettes

12.10 Concluding remarks

Acknowledgments

References

Attachment 12.1 Health warnings

Attachment 12.1 References

Attachment 12.2 Reduced fire risk (RFR) cigarettes

Attachment 12.2 References

Attachment 12.3 Smokeless tobacco and harm reduction

Attachment 12.3 References

1. Ramström LM, Snuff – an alternative nicotine delivery system. In: Ferrence R, Slade J, Room R, Pope M, eds. Nicotine and Public Health. Washington, DC: American Public Health Association 2000.

2. Ramström LM, Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tobacco Control 2006; 15: 210–4.

3. Tomar SL, Connolly GN, Wilkenfeld J, Henningfield JE. Declining smoking in Sweden: is Swedish Match getting the credit for Swedish tobacco control's efforts? Tobacco Control 2003; 12: 368–71.

4. Critchley JA, Unal B. Is smokeless tobacco a risk factor for coronary heart disease? A systematic review of epidemiological studies. European Journal of Cardiovascular Prevention and Rehabilitation 2004; 11: 101–12.

5. Foulds J, Ramström L, Burke M, Fagerström K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tobacco Control 2003; 12: 349–59.

6. Luo J, Ye W, Zendehdel K, Adami J, Adami H, Boffetta P, et al. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. The Lancet. 2007;369:2015–20. Available from: http://www.thelancet.com/journals/lancet/article/PIIS0140673607606783/abstract

7. Boffetta P, Aagnes B, Weiderpass E, Andersen A. Smokeless tobacco use and risk of cancer of the pancreas and other organs. International Journal of Cancer 2005; 114: 992–5.

8. Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. American Journal of Public Health 1994; 84: 399–404.

9. Persson P-G, Carlsson S, Svanstrom L, Ostenson C-G, Efendic S, Grill V. Cigarette smoking, oral moist snuff use and glucose intolerance. Journal of Internal Medicine 2000; 248: 103–10.

10. Eliasson M, Asplund K, Nasic S, Rodu B. Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study. Journal of Internal Medicine 2004; 256: 101–10.

11. Larsson A, Axell T, Andersson G. Reversibility of snuff dippers' lesion in Swedish moist snuff users: A clinical and histologic follow-up study. Journal of Oral Pathology and Medicine 1991; 20: 258–64.

12. Gartner C, Hall W, Vos T, Bertram M, Wallace A and Lim S. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. The Lancet. 2007;369:2010–4. Available from: http://www.thelancet.com/journals/lancet/article/PIIS0140673607606771/abstract

13. Henley SJ, Connell CJ, Richter P, Husten C, Pechacek T, Calle EE, et al. Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco. Tobacco Control 2007; 16: 22–8.

14. Kozlowski LT. Harm reduction, public health, and human rights: Smokers have a right to be informed of significant harm reduction options. Nicotine and Tobacco Research 2002; 4: S55–S60.

15. Fagerström K. Quit or Die: Nothing in between? Respiration 2002; 69: 387–8.

16. Kozlowski LT. First, tell the truth: A dialogue on human rights, deception, and the use of smokeless tobacco as a substitute for cigarettes. Tobacco Control 2003; 12: 34–6.

17. Waterbor JW, Adams RM, Robinson JM, Crabtree FG, Accortt NA, Gilliland MJ. Disparities between public health educational materials and the scientific evidence that smokeless tobacco use causes cancer. Journal of Cancer Education 2004; 19: 17–28.

18. Tobacco Advisory Group of the Royal College of Physicians. Protecting Smokers, Saving Lives: The Case for a Tobacco and Nicotine Regulatory Authority. London: Royal College of Physicians of London 2002.

19. Gartner CE, Hall WD, Chapman S and Freeman B. Should the health community promote smokeless tobacco (snus) as a harm reduction measure? Public Library of Science Medicine. 2007;4:e185. Available from: http://www.plos.org

20. Doran CM, Valenti L, Robinson M, Britt H, Mattick RP. Smoking status of Australian general practice patients and their attempts to quit. Addictive Behaviors 2006; 31: 758–66.